As the session nears the end, there are several key dates to keep in mind. All Senate bills must pass the House committees by February 27, and all House bills must pass the Senate committees by February 29.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Family and Social Services Administration’s (FSSA) Health Coverage Programs (IHCP) provided pharmacy updates approved by the Drug Utilization Board.
Also in Indiana, SB 192, legislation allowing a pharmacist to administer any immunization that is recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) under a drug order, a prescription or a physician protocol, died in the House Appropriations Committee. Current law restricts the types of vaccines that can be administered under a physician protocol.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
More than 200 pharmacists, students and pharmacy technicians participated in the Indiana Pharmacy Association’s annual Legislative Day at the Capitol that NACDS sponsored. Attendees were briefed on the priority issues before their meetings with state legislators.
Also in Indiana, HB 1327 passed the House by a vote of 93-4 and was referred to the Senate for further action.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
SB 192, broad healthcare legislation that includes a provision allowing pharmacy personnel to provide any immunization recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) to patients 11 years of age and older under a physician protocol, was referred to the Committee on Health and Provider Services.
Also in Indiana, NACDS sent a support letter for HB 1327, legislation that will provide transparency and audit authority needed to make PBMs accountable to the organizations that hire them. NACDS asked the Committee to reject any amendments that would allow PBMs and Third-Party Administrators to charge a “carve out fee” for not using an affiliate pharmacy owned by or invested in by a PBM or Third Party Administer.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
NACDS is a proud sponsor of the Indiana Pharmacy Associations’ (IPA) annual Legislative Day at the Indiana State House. The advocacy event allows pharmacists, students and pharmacy technicians to educate legislators about the importance of pharmacies as a convenient, accessible community healthcare destination, as well as an opportunity to promote pharmacists and technicians as vital members of the healthcare team.
Also in Indiana, the Family and Social Services Administration’s (FSSA) Indiana Health Coverage Programs (IHCP) issued Bulletin 2023181 updating billing guidance for Novavax COVID-19 vaccinations. The reimbursement is carved out of managed care benefits.
Also in Indiana, all pharmacy groups are strongly supporting SB 192, legislation that would allow pharmacists to administer all Advisory Committee on Immunization Practices (ACIP)-approved vaccines to anyone 11 years of age and older under a physician protocol.
Finally in Indiana, HB 1327, a PBM audit and transparency bill supported by the Employers Group of Indiana, was heard in the House Public Health Committee on January 16.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The legislature convened its 60-day short session on January 8.
Also in Indiana, the state Health Coverage programs (IHCP) issued two bulletins of interest to pharmacies:
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Health Coverage Programs (IHCP) issued a bulletin reminding pharmacy providers to submit claims with the appropriate DAW codes.
Also in Indiana, after four interim legislative hearings, the Health Care Cost Oversight Task Force issued a report with seven recommendations for legislation, including increasing transparency and prohibiting spread pricing by PBMs, third parties and insurers.
Finally in Indiana, the IHCP Bulletin 2023168 provides informational updates on the November Drug Utilization Review (DUR) Board.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Family and Social Services Administration (FSSA) provided pharmacy updates approved by Drug Utilization Review Board in October.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Indiana Health Coverage Programs (IHCP) posted Bulletin # BT2023138 regarding reprocessing claims for certain glucose monitor procedure codes.
For more information, contact NACDS’ Mary Staples at 817-442-1155.